Calidi Biotherapeutics (CLDI) Interest Expenses (2021 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Interest Expenses of -$48.5 million for Q4 2025, down 13732.87% year-over-year from N/an in Q4 2024, and down 26476.63% quarter-over-quarter from $184000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Interest Expenses (2021 - 2026) Analysis & Trends
Calidi Biotherapeutics' Interest Expenses history runs 5 years deep, the most recent figure standing at -$48.5 million for Q4 2025.
- In Q4 2025, Interest Expenses fell 13732.87% year-over-year to -$48.5 million; the TTM figure through Dec 2025 stood at -$27.5 million (down 6816.59% YoY), while the FY2025 annual figure was $34.2 million, up 16.37% from the prior year.
- Interest Expenses for Q4 2025 stood at -$48.5 million, down from $184000.0 in the prior quarter.
- The five-year high for Interest Expenses was $20.0 million in Q2 2025, with the low at -$48.5 million in Q4 2025.
- The 5-year median for Interest Expenses is $457378.0 (2021), against an average of -$1.1 million.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses surged 15886.21% in 2023, then slumped 13732.87% in 2025.
- Calidi Biotherapeutics' Interest Expenses stood at $457378.0 in 2021, then jumped by 66.82% to $763000.0 in 2022, then tumbled by 176.67% to -$585000.0 in 2023, then jumped by 160.85% to $356000.0 in 2024, then plunged by 13732.87% to -$48.5 million in 2025.
- Business Quant data shows CLDI's Interest Expenses at -$48.5 million in Q4 2025, $184000.0 in Q3 2025, and $20.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | 29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Jun 30, 2026 | 1.06 Mn |
| Dec 31, 2025 | -48.53 Mn |
| Dec 31, 2025 | -48.53 Mn |
| Sep 30, 2025 | 184,000.00 |
| Sep 30, 2025 | 184,000.00 |
| Jun 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 639,000.00 |
| Mar 31, 2025 | 639,000.00 |
| Dec 31, 2024 | 356,000.00 |
| Dec 31, 2024 | 356,000.00 |
| Sep 30, 2024 | 498,000.00 |
| Sep 30, 2024 | 498,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Mar 31, 2024 | 4.53 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | -585,000.00 |
| Dec 31, 2023 | -585,000.00 |